Here, we found that, similarly, AIM2 expression in CD14+ PBMCs (Figure 1A,B) was statistically increased in COPD patients compared to smokers and healthy subjects (Figure 1B). Here, AIM2 is linked to chronic obstructive pulmonary disease.